These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 25778313)
1. miR-150 is a factor of survival in prostate cancer patients. Dezhong L; Xiaoyi Z; Xianlian L; Hongyan Z; Guohua Z; Bo S; Shenglei Z; Lian Z J BUON; 2015; 20(1):173-9. PubMed ID: 25778313 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of microRNA-93 downregulation in human colon cancer. Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603 [TBL] [Abstract][Full Text] [Related]
9. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291 [TBL] [Abstract][Full Text] [Related]
11. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219 [TBL] [Abstract][Full Text] [Related]
12. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer. Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252 [TBL] [Abstract][Full Text] [Related]